Compare McKesson Corporation (MCK) vs Open Text Corporation (OTEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
McKesson Corporation vs Open Text Corporation — how do they compare? McKesson Corporation trades at $828.8 (market cap $97.35B), while Open Text Corporation trades at $23.13 (market cap $5.61B). The key difference: McKesson Corporation is far larger — about 17.4× Open Text Corporation's market cap, and Open Text Corporation pays the higher dividend (4.72%). Which is the better fit depends on your goals.
| MCK | OTEX | |
|---|---|---|
Market Cap | $97.35B | $5.61B |
Sector | Health | Technology |
52-Week High | $995.69 | $39.69 |
52-Week Low | $659.01 | $20.01 |
Enterprise Value | $101.98B | $10.77B |
Dividend Yield | 0.39% | 4.72% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
McKesson Corporation (MCK) trades at $831.60, down 1.16% on the day, with a bullish technical signal and positive earnings momentum after beating estimates for three consecutive quarters. The stock shows strong analyst support with an 80% buy rating and a consensus price target of $932.83, implying potential upside. Revenue growth is robust, reaching $359.05 billion in 2025, though net margins remain thin at 1.18%. Cash flow from operations improved to $6.09 billion in 2025, supporting financial stability.
The outlook for MCK is positive, driven by earnings beats, analyst optimism, and solid cash generation. Key opportunities include growth in specialty pharma and oncology services. Risks involve policy uncertainties, competitive pressures, and execution challenges. The stock's current price near key support at $829 suggests a critical level for near-term direction.
OpenText (OTEX) trades at $23.33, up 0.26% with a bullish technical signal from moving averages. The company shows solid fundamentals with a P/E of 11.3, EV/EBITDA of 6.71, and consistent earnings beats in recent quarters. Recent developments include a $105 million European AI investment and board appointments, while maintaining a 4.7% dividend yield.
OTEX presents value opportunity with attractive valuation multiples and strong cash flow generation. Key risks include execution challenges in AI strategy and competitive software market pressures. Analyst consensus targets $29.75 (27.5% upside) with 42% buy ratings, though majority maintain hold stance awaiting clearer growth catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →
